Status:
UNKNOWN
Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Nearsightedness
Farsightedness
Eligibility:
All Genders
Brief Summary
The purpose of this combined retrospective and prospective chart review analysis is to investigate the safety, efficacy, and predictability obtained via Laser-Assisted In Situ Keratomileusis (LASIK) a...
Detailed Description
Excimer laser vision correction (LVC) is a widely used procedure to correct nearsightedness, farsightedness, and astigmatism by reshaping the surface of the eye (cornea). Laser-Assisted In Situ Kerato...
Eligibility Criteria
Inclusion
- Eyes that were treated for LASIK or ASA Excimer laser vision correction before December 1st 2006 and newly recruited eyes that qualify for LASIK or ASA Excimer laser vision correction may be enrolled in this study.
Exclusion
- There are no exclusion criteria; all patients that went forward with Excimer laser vision correction may be included.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00778570
Start Date
February 1 2007
End Date
December 1 2020
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Eye Institute
Ottawa, Ontario, Canada, K1H 8L6